Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-007856

EXEC. VP AND CLO sold 75,420 shares at an average $53.08 ($4,003,305)

  • EXEC. VP AND CLO acquired 75,420 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Option exercise 10b5-1 +45,392 $33.02 $1,498,844 149,293 D: show line 1 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Sale 10b5-1 −45,392 $53.15 $2,412,585 103,901 D: show line 2 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Option exercise 10b5-1 +11,398 $33.02 $376,362 115,299 D: show line 3 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Sale 10b5-1 −11,398 $53.12 $605,462 103,901 D: show line 4 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Option exercise 10b5-1 +11,249 $25.69 $288,987 115,150 D: show line 5 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Sale 10b5-1 −3,487 $52.24 $182,161 111,663 D: show line 6 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Sale 10b5-1 −7,762 $53.05 $411,774 103,901 D: show line 7 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-11 Option exercise 10b5-1 +5,662 $33.02 $186,959 109,563 D: show line 8 in the form
Open-market sales · 75,420 sh · avg $53.08 · $4,003,305

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Option exercise · Stock Option (Right to Buy) 10b5-1 −45,392 18,788 D: show line 12 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Option exercise · Stock Option (Right to Buy) 10b5-1 −11,398 4,114 D: show line 13 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-10 Option exercise · Stock Option (Right to Buy) 10b5-1 −11,249 33,751 D: show line 14 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,662 13,126 D: show line 15 in the form
Boulding Mark Elliott EXEC. VP AND CLO 2025-03-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,719 2,395 D: show line 16 in the form
Loading xslF345X05/form4-03122025_050301.xml…